Pages

▼
Tuesday, July 08, 2025

The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market

›
The 2025 launch of biosimilars to Johnson & Johnson’s Stelara (ustekinumab) marks another turning point in pharmacy benefit dynamics. Bu...
Tuesday, June 24, 2025

Drug Channels News Roundup, June 2025: PBM Rebate Flow, 340B’s 2024 Boom, IRA Fallout, MFN Legal Risks—and Mark Cuban’s PBM Rant

›
Happy 249th birthday, America! Before you launch your July 4 festivities, Drug Channels humbly offers some fact-based fireworks to heal our...
Friday, June 20, 2025

Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, ...
Thursday, June 19, 2025

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI’s 2025 Update and Competitive Outlook (rerun)

›
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: What’s Next for Retail Pharmacy: Data, D...
Wednesday, June 18, 2025

The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate,...
Tuesday, June 17, 2025

The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate,...
Monday, June 16, 2025

The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate,...
Friday, June 13, 2025

Starting with the End in Mind: How Pharma Can Build a Smarter Path to Commercialization

›
Today’s guest post comes from Sean Wagner, VP of Client Partnerships and Carolyn Zele, Advisor, Solution Consulting at MMIT. Sean and Car...
Tuesday, June 10, 2025

The 340B Contract Pharmacy Market in 2025: Big Chains and PBMs Tighten Their Grip

›
The 340B Drug Pricing Program has emerged as a growing source of profits for pharmacies and pharmacy benefit managers (PBMs). Drug Channels ...
Friday, June 06, 2025

Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability

›
Today’s guest post comes from Logan Melchione, VP of Patient Affordability at Paysign. Logan explores how maximizers have reshaped the pa...
Tuesday, June 03, 2025

Pharmacist Salaries and Employment in 2024: Retail Employment Collapse Offset by Hospital Boom

›
It’s time for Drug Channels’ annual look at pharmacist salaries and employment. There was more bad news, as employment in retail pharmaci...
Friday, May 30, 2025

Three Ways GoodRx Is Helping Pharmacies Increase Profitability and Drive Innovation

›
Today’s guest post comes from Aaron Crittenden, President of Rx Marketplace at GoodRx. Aaron introduces us to GoodRx Community Link , a n...